Jinwon Life Sciences Signs Plasmid DNA Supply Contract Worth 1.74 Million USD
GeneOne Life Science announced on the 22nd that it has signed a plasmid DNA pharmaceutical supply contract worth 1.74 million USD with a U.S. biotech company.
The name of the contracting party cannot be disclosed according to a confidentiality clause in the contract, and the contract amount is approximately 2.42 billion KRW when converted to Korean won.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While Everyone Focused on Samsung and Nix, This Company Soared 50%... Hit Record Highs for 4 Days [Weekend Money]
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- Incoming Fed Chairman Kevin Walsh to Sell $2.52 Million Worth of Coupang Shares
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
Park Young-geun, CEO of GeneOne Life Science, stated, “We are continuously negotiating orders with clients through active sales activities,” adding, “Our subsidiary VGXI’s new factory has been recognized for its high-quality plasmid DNA supply capabilities, so additional orders are expected to follow.”
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
